UTHealth Women’s Research Program-Memorial City
UTHealth Women’s Research Program – Memorial City
UTHealth Women’s Research Program – Memorial City is a research study site, led by Dr. Sandra Hurtado. Dr. Hurtado is a board-certified obstetrician-gynecologist, with over 25 years of combined research and women’s health care experience. She leads the team as the Principal Investigator within the clinical trials.
Current and Enrolling Clinical Trials:
Click on each study name for additional details.
- ELARIS EM-COC
- Endometriosis
- MOXIE
- Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Women with Uterine Fibroids or Endometriosis
- The Marguerite Study
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With RSV Vaccine and Duration of Protection of a Single Dose.
- Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
Each clinical trial has differing eligibility criteria for participation, therefore if you are interested participating, please contact us directly to further discuss the studies and eligibility criteria.
Sandra M. Hurtado, MD
Principal Investigator
Lori Wink, NP
Clinical Research Manager
Rupal Patel, RN, BS, CCRC
Senior Research Nurse
Cecilia Gonzalez
Research Coordinator II
Contact Us
UTHealth Women’s Research Program – Memorial City
925 Gessner Road
Suite 575
Houston, Texas 77024
Phone: (713) 486-6640
Fax: (713) 486-6641
E-mail: [email protected]
In the News
Fox26 Interview with Dr. Sandra Hurtado
National Geographic- Pfizer and Moderna Vaccines Safe For Pregnant People